Atlas Trials

A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder

Clinical trial NCT02432703 · COMPLETED

Trial details

NCT number
NCT02432703
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Phobic Disorders
Start date
2015-06-11
Primary completion
2018-08-09
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.